BFM
IBIO icon

Boothbay Fund Management’s iBio IBIO Stock Holding History

Boothbay Fund Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$483K Hold
254,412
– – 0.01% 1376
2025
Q4 		$491K Buy
254,412
+77,550
+44% +$106K 0.01% 1151
2025
Q3 		$146K Buy
176,862
+17,414
+11% +$13.4K ﹤0.01% 1692
2025
Q2 		$122K Hold
159,448
– – ﹤0.01% 1297
2025
Q1 		$641K Hold
159,448
– – 0.02% 776
2024
Q4 		$391K Sell
159,448
-87
-0.1% -$224 0.01% 976
2024
Q3 		$354K Hold
159,535
– – 0.01% 1138
2024
Q2 		$337K Buy
+159,535
New +$343K 0.01% 1120

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Boothbay Fund Management's IBIO Position: Q1 2026 in Review

Boothbay Fund Management held its iBio (IBIO) position steady in Q1 2026 at 254,412 shares worth $483K. The position accounts for 0.01% of the portfolio, ranked #1376.

Boothbay Fund Management first reported a position in IBIO in Q2 2024 and has held it in 8 quarters since. The position peaked at $641K in Q1 2025. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Boothbay Fund Management held 254,412 shares of iBio worth $483K as of Q1 2026.
  • Boothbay Fund Management left its iBio share count unchanged in Q1 2026.
  • iBio made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1376 holding.
  • Boothbay Fund Management first reported a position in iBio in Q2 2024 and has held it in 8 quarters since.
  • Boothbay Fund Management's iBio position peaked at $641K in Q1 2025.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.